Walleye Capital’s Core Laboratories CLB Stock Holding History

Walleye Capital’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,993	Closed	-$204K	–	4922
2024 Q3	$204K	Buy	+10,993	New	+$221K	﹤0.01%	3994

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's CLB Position: Q4 2024 in Review

Walleye Capital sold out of Core Laboratories (CLB) in Q4 2024, closing a stake of 10,993 shares — an estimated $204K sold.

Walleye Capital first reported a position in CLB in Q3 2024 and held it in 1 quarter. The position peaked at $204K in Q3 2024. 209 funds tracked by Wall St. Rank hold CLB as of Q4 2024.

Walleye Capital reported no remaining Core Laboratories position as of Q4 2024 after selling out during the quarter.
Walleye Capital sold 10,993 Core Laboratories shares in Q4 2024, an estimated $204K.
Walleye Capital first reported a position in Core Laboratories in Q3 2024 and held it in 1 quarter.
Walleye Capital's Core Laboratories position peaked at $204K in Q3 2024.
209 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2024.

Based on Walleye Capital's 13F filing for Q4 2024, filed 13 Feb 2025.